Gastric Bypass Surgery Offers Long-Term Resolution of Diabetes
|
By HospiMedica International staff writers Posted on 06 Jul 2009 |
A new study has found that bariatric surgery is one of the most effective long-term treatments for morbidly obese patients with type 2 diabetes.
Researchers at the Virginia Commonwealth University (VCU; Richmond, USA) conducted a retrospective analysis of 177 people with morbid obesity and type 2 diabetes that underwent gastric bypass surgery between 1993 and 2003. The researchers divided patients into three categories, based on their diabetes treatment prior to surgery: insulin dependent (59); oral medications (83); or diet and lifestyle changes only (35). The patients were followed from 5 to 16 years. The researchers found that the patients who had a recurrence of diabetes regained about 10% more of their excess weight than those with no recurrence. Those most likely to experience a recurrence of diabetes regained the most weight or had a more severe insulin-dependent form of diabetes prior to surgery; on average, patients who remain free of diabetes had excess weight loss of about 73%, while diabetes returned in those that had 66% or less excess weight loss. More than 75% of patients who were controlling their diabetes with dietary and lifestyle management and more than 65% who were using oral medications before surgery continued to be diabetes-free after gastric bypass surgery. About 70% of insulin-dependent patients had a recurrence of diabetes independent of weight loss or gain, and 40% of those who regained about 20% of the weight also experienced a return of the disease. In all, nearly 90% of morbidly obese patients with type 2 diabetes experienced diabetes resolution within the first year of gastric bypass surgery, and about 60% remained diabetes-free 5 to 16 years later.
The study was presented at the 26th annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS), held during June 2009 in Grapevine (TX, USA).
"The severity of the diabetes at the time of surgery and the regain of excess weight loss long-term seem to be the primary determinants of long-term diabetes resolution after gastric bypass surgery,” said study presenter and coauthor Professor James Maher, M.D. "This study suggests that people with Type 2 diabetes and morbid obesity who get surgery before becoming insulin-dependent have the greatest chance for complete resolution and avoiding the progression of diabetes.”
People who are morbidly obese have a body mass index (BMI) score of 40 or more, or a BMI of 35 or more with an obesity-related disease, such as type 2 diabetes, heart disease, or sleep apnea. The American Diabetes Association (ADA) recently recommended that bariatric surgery be considered for adults with a BMI score of over 35 and Type 2 diabetes, especially if diabetes is difficult to control under their current therapy. The most common methods of bariatric surgery are laparoscopic gastric bypass and laparoscopic adjustable gastric banding (LAGB).
Related Links:
Virginia Commonwealth University
Researchers at the Virginia Commonwealth University (VCU; Richmond, USA) conducted a retrospective analysis of 177 people with morbid obesity and type 2 diabetes that underwent gastric bypass surgery between 1993 and 2003. The researchers divided patients into three categories, based on their diabetes treatment prior to surgery: insulin dependent (59); oral medications (83); or diet and lifestyle changes only (35). The patients were followed from 5 to 16 years. The researchers found that the patients who had a recurrence of diabetes regained about 10% more of their excess weight than those with no recurrence. Those most likely to experience a recurrence of diabetes regained the most weight or had a more severe insulin-dependent form of diabetes prior to surgery; on average, patients who remain free of diabetes had excess weight loss of about 73%, while diabetes returned in those that had 66% or less excess weight loss. More than 75% of patients who were controlling their diabetes with dietary and lifestyle management and more than 65% who were using oral medications before surgery continued to be diabetes-free after gastric bypass surgery. About 70% of insulin-dependent patients had a recurrence of diabetes independent of weight loss or gain, and 40% of those who regained about 20% of the weight also experienced a return of the disease. In all, nearly 90% of morbidly obese patients with type 2 diabetes experienced diabetes resolution within the first year of gastric bypass surgery, and about 60% remained diabetes-free 5 to 16 years later.
The study was presented at the 26th annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS), held during June 2009 in Grapevine (TX, USA).
"The severity of the diabetes at the time of surgery and the regain of excess weight loss long-term seem to be the primary determinants of long-term diabetes resolution after gastric bypass surgery,” said study presenter and coauthor Professor James Maher, M.D. "This study suggests that people with Type 2 diabetes and morbid obesity who get surgery before becoming insulin-dependent have the greatest chance for complete resolution and avoiding the progression of diabetes.”
People who are morbidly obese have a body mass index (BMI) score of 40 or more, or a BMI of 35 or more with an obesity-related disease, such as type 2 diabetes, heart disease, or sleep apnea. The American Diabetes Association (ADA) recently recommended that bariatric surgery be considered for adults with a BMI score of over 35 and Type 2 diabetes, especially if diabetes is difficult to control under their current therapy. The most common methods of bariatric surgery are laparoscopic gastric bypass and laparoscopic adjustable gastric banding (LAGB).
Related Links:
Virginia Commonwealth University
Latest Surgical Techniques News
- New Study Findings Could Halve Number of Stent Procedures
- Breakthrough Surgical Device Redefines Hip Arthroscopy
- Automated System Enables Real-Time "Molecular Pathology" During Cancer Surgery
- Groundbreaking Procedure Combines New Treatments for Liver Tumors
- Ablation Reduces Stroke Risk Associated with Atrial Fibrillation
- Optical Tracking Method Identifies Target Areas in Robot-Assisted Neurosurgery
- General Anesthesia Improves Post-Surgery Outcomes for Acute Stroke Patients
- Drug-Coated Balloons Can Replace Stents Even in Larger Coronary Arteries
- Magnetic Kidney Stone Retrieval Device Outperforms Ureteroscopic Laser Lithotripsy
- Absorbable Skull Device Could Replace Traditional Metal Implants Used After Brain Surgery
- Magic Silicone Liquid Powered Robots Perform MIS in Narrow Cavities
- 'Lab-on-a-Scalpel' Provides Real-Time Surgical Insights for POC Diagnostics in OR
- Biodegradable Brain Implant Prevents Glioblastoma Recurrence
- Tiny 3D Printer Reconstructs Tissues During Vocal Cord Surgery
- Minimally Invasive Procedure for Aortic Valve Disease Has Similar Outcomes as Surgery
- Safer Hip Implant Design Prevents Early Femoral Fractures
Channels
Critical Care
view channel
Magnetically Guided Microrobots to Enable Targeted Drug Delivery
Stroke affects 12 million people globally each year, often causing death or lasting disability. Current treatment relies on systemic administration of clot-dissolving drugs, which circulate throughout... Read more
Smart Nanomaterials Detect and Treat Traumatic Brain Injuries Simultaneously
Traumatic brain injury (TBI) continues to leave millions with long-term disabilities every year. After a sudden impact from a fall, collision, or accident, the brain undergoes inflammation, oxidative stress,... Read more
Earlier Blood Transfusion Could Reduce Heart Failure and Arrhythmia in Heart Disease Patients
Blood loss during or after surgery can place significant stress on people with heart disease, increasing the risk of dangerous complications. Transfusions are often delayed until hemoglobin levels fall... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more
CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more







